Silico Therapeutics
San Francisco · Founded 2017
About Silico Therapeutics
Silico Therapeutics provides platform that personalize CRISPR mediated genomic treatment. CRISPR technology could allow the modification of any genetic mutation at will, curing any disease with a genetic origin
Company Facts
- Founded: 2017
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jan 2021)
- Website: silicotx.com
Canonical: https://fsome.com/organization/silico-therapeutics-8406920 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.